BusinessTRACON Pharmaceuticals to Present at the 28th Annual Roth ConferenceBy Nasdaq OMXMar 7, 2016, 9:05 PM UTC
BusinessKemPharm Files IND for KP511, an Investigational Prodrug of HydromorphoneBy Nasdaq OMXMar 7, 2016, 2:40 PM UTC
BusinessCancer Genetics, Inc. Launches Next Generation Sequencing Panel for Diagnosis & Treatment Selection in Solid Tumors, CGI FOCUS::Oncomine™By Nasdaq OMXMar 7, 2016, 2:37 PM UTC
BusinessVericel Announces FDA Acceptance for Filing of BLA for MACI for the Treatment of Symptomatic Cartilage Defects in the KneeBy Nasdaq OMXMar 7, 2016, 2:15 PM UTC
BusinessCellect Announces Receipt of IRB Approval to Conduct Its Clinical Trial in Leukemia PatientsBy Nasdaq OMXMar 7, 2016, 2:00 PM UTC
BusinessAnthera Pharmaceuticals Announces Appointment of Dr. James Pennington as Interim Chief Medical OfficerBy Nasdaq OMXMar 7, 2016, 1:37 PM UTC
BusinessVBI Vaccines Presents New Data Supporting its Glioblastoma Immunotherapy Program at the Keystone Symposia Cancer Vaccines ConferenceBy Nasdaq OMXMar 7, 2016, 1:30 PM UTC
BusinessBeiGene Receives Approval to Initiate Clinical Trials in China With BGB-3111By Nasdaq OMXMar 7, 2016, 1:00 PM UTC
